A federal judge recently pushed the legal pause button on several of the Trump administration’s new vaccine policies, the latest development in the United States’ rapidly chan ...
Vaccine programmes are being challenged by rising misinformation and an uncertain pipeline for research funding, the World ...
The vaccine was previously approved in the US to prevent LRTD related to RSV infection in adults 60 years or older and ...
A federal work group says Covid vaccine injuries deserve urgent attention, even as Health Secretary Robert F. Kennedy Jr.
If you're looking for the most hated stocks on Wall Street, start with this list. All seven companies are worth more than $1 ...
However, the vaccine manufacturers concerned may appeal against this decision in order to protect their professional, ...
Novavax reported fourth-quarter earnings of 11 cents, a shift from a loss of 51 cents a year ago. evenue for the fourth quarter was $147 million, a 67% year-over-year increase. Novavax on Thursday ...
Feb 26 (Reuters) - Novavax raised its adjusted revenue forecast for 2026 on Thursday, banking on milestone payments from licensing and supply deals for its shots, although it noted that the current ...
GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Thursday reported fourth-quarter earnings of $17.5 million. On a per-share basis, the Gaithersburg, Maryland-based company said ...
Moderna researchers at work in the company’s lab. The FDA’s reversal of its earlier refusal to review mRNA-1010, the seasonal flu vaccine being developed by Moderna accelerated a revival of its shares ...
2024-2025 COVID-19 vaccines reduced hospitalization risk by 40% against JN.1 lineage variants. COVID-19 is still a public threat and health concern. Between 2024 and 2025, an estimated 380,000 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results